The FDA cannot come back with other issues. The FDA procedures explain the approval process, and the only matter they required a company response on were the written instructions and also their inclusion on the packaging. So according to the FDA themselves, there is no issue with the science or 'other' matters.
BOT - Anything but charting, page-8858
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
37.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $672.4M | |||
| Open | High | Low | Value | Volume |
| 37.5¢ | 38.0¢ | 36.5¢ | $993.3K | 2.673M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 16 | 278064 | 36.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 37.0¢ | 25974 | 2 |
View Market Depth
| Last trade - 16.10pm 14/10/2024 (20 minute delay) ? |
| BOT (ASX) Chart |